Vaxart, Inc. (VXRT)
0.36
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
Vaxart Price : 0.36 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 0.3515 | 0.36 | 0.35 | 0.36 | 358311.0 |
| Nov 18, 2026 | 0.3616 | 0.3655 | 0.35 | 0.355 | 245774.0 |
| Nov 17, 2026 | 0.3516 | 0.37 | 0.35 | 0.355 | 400756.0 |
| Nov 16, 2026 | 0.36 | 0.3773 | 0.355 | 0.3617 | 253336.0 |
| Nov 13, 2026 | 0.37 | 0.3765 | 0.36 | 0.3677 | 174372.0 |
| Nov 12, 2026 | 0.36 | 0.3805 | 0.36 | 0.37 | 312466.0 |
| Nov 11, 2026 | 0.367 | 0.3760 | 0.36 | 0.365 | 242025.0 |
| Nov 10, 2026 | 0.366 | 0.38 | 0.36 | 0.362 | 446032.0 |
| Nov 09, 2026 | 0.3685 | 0.391 | 0.366 | 0.37 | 232435.0 |
| Nov 06, 2026 | 0.391 | 0.391 | 0.3641 | 0.37 | 311366.0 |
| Nov 05, 2026 | 0.405 | 0.405 | 0.365 | 0.365 | 434774.0 |
| Nov 04, 2026 | 0.395 | 0.4095 | 0.39 | 0.40 | 142639.0 |
| Nov 03, 2026 | 0.4052 | 0.4136 | 0.3851 | 0.40 | 339848.0 |
| Nov 02, 2026 | 0.42 | 0.44 | 0.40 | 0.4101 | 181193.0 |
| Oct 30, 2026 | 0.427 | 0.4399 | 0.39 | 0.43 | 323223.0 |
| Oct 29, 2026 | 0.3995 | 0.437 | 0.3995 | 0.4246 | 245738.0 |
| Oct 28, 2026 | 0.40 | 0.44 | 0.3501 | 0.408 | 576971.0 |
| Oct 27, 2026 | 0.40 | 0.4199 | 0.398 | 0.399 | 207933.0 |
| Oct 26, 2026 | 0.41 | 0.442 | 0.398 | 0.405 | 352786.0 |
| Oct 23, 2026 | 0.449 | 0.4499 | 0.41 | 0.41 | 339460.0 |
| Oct 22, 2026 | 0.4797 | 0.48 | 0.44 | 0.441 | 330887.0 |
| Oct 21, 2026 | 0.4898 | 0.4934 | 0.47 | 0.475 | 117102.0 |
| Oct 20, 2026 | 0.453 | 0.494 | 0.453 | 0.49 | 89499.00 |
| Oct 19, 2026 | 0.45 | 0.525 | 0.4456 | 0.4755 | 792161.0 |
| Oct 16, 2026 | 0.47 | 0.4911 | 0.44 | 0.4527 | 201772.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.17 |
| Amgen, Inc. | 440.50 |
| Anika Therapeutics, Inc. | 13.55 |
| BioCryst Pharmaceuticals, Inc. | 7.32 |
| Imunon, Inc. | 0.584 |
Price Related Metrics
| PE Ratio | 2.956 |
| PS Ratio | 0.4806 |
| Price to Book Value | 1.323 |
| Price to Free Cash Flow | 2.725 |
| Earnings Yield | 33.83% |
| Market Cap | 87.73M |
| Operating PE Ratio | 2.890 |
| Normalized PE Ratio | 2.956 |